2 news items
MAIA Biotechnology's Unique Telomere Targeting Agent Currently In Clinical Development Shows Promise For The Multi-Billion Dollar Cancer Therapy Market
MAIA
22 May 24
for cancer treatment. The company's mission is to discover, develop and deliver transformative cancer therapies that improve patients' lives worldwide
MAIA Biotechnology Abstract Accepted for Poster Presentation at American Society of Clinical Oncology (ASCO) 2024 Annual Meeting
MAIA
16 May 24
for physicians and oncology professionals caring for people with cancer. Its mission is to conquer cancer through research, education, and promotion
- Prev
- 1
- Next